{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:03:46Z","timestamp":1792569826745,"version":"4.5.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T00:00:00Z","timestamp":1752105600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Primary intestinal lymphangiectasia or Waldmann\u2019s disease (ORPHA code: 90362) is a very rare disorder of unknown etiology, characterized by digestive lymphatic vessel dilations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main body of the abstract<\/jats:title>\n            <jats:p>The objective of the French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins) is to provide health professionals with information about the optimal management and care for patients, based on a critical literature review and multidisciplinary expert consensus. The PNDS, written by members of the French National Reference Centers for Rare Vascular diseases and Rare Digestive diseases, is available from the French Health Authority website. The latter allow lymph leakage (chyle) into the intestinal lumen that is responsible for protein-losing gastroenteropathy, combining hypoalbuminemia, lymphopenia and hypogammaglobulinemia. Diagnosis is usually made before the age of 3, but primary intestinal lymphangiectasia may be discovered in adults. Edema of the lower limbs is the main clinical sign and serous effusions (pleura, peritoneum, pericardium) are sometimes abundant. Exudative gastroenteropathy is confirmed by increased \u03b1<jats:sub>1<\/jats:sub>-antitrypsin clearance. Esophagogastroduodenoscopy finds milky lesions corresponding to lymphangiectasias; duodenal biopsies confirm the diagnosis. Endoscopic videocapsule may be useful to evaluate the extent of the disease and\/or if esophagogastroduodenoscopy is not contributory. In rare cases, the disease may be complicated by digestive or extra-digestive B-cell lymphoma in adults. Management is mainly based on a strict fat-free diet, combined with supplementation with medium-chain triglycerides, essential fatty acids and fat-soluble vitamins. Octreotide, a somatostatin analogue, has inconsistent efficacy, in combination with the fat-free diet and the sometimes-prescribed mammalian target of rapamycin-receptor inhibitor sirolimus, occasionally achieving positive effects. Diuretics and albumin infusions may be useful in addition to the fat-free diet. Intestinal resections are proposed for rare, localized, segmental forms of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Short conclusion<\/jats:title>\n            <jats:p>Primary intestinal lymphangiectasia is a chronic disease requiring a prolonged restrictive and constraining strict low-fat diet supplemented with medium-chain triglycerides and fat-soluble vitamins. Its evolution can be complicated by more-or-less severe serous effusions and rare lymphoma. Life-long clinical and biological monitoring is required.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03657-9","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T13:37:48Z","timestamp":1752154668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Primary intestinal lymphangiectasia: French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins)"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-1469","authenticated-orcid":false,"given":"St\u00e9phane","family":"Vignes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Uzzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Arriv\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Le Pimpec-Barthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fieschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Lef\u00e8vre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manon","family":"Javalet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Bettolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Dubern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,10]]},"reference":[{"key":"3657_CR1","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0016-5085(19)35130-3","volume":"41","author":"TA Waldmann","year":"1961","unstructured":"Waldmann TA, Steinfeld JL, Dutcher TF, Davidson JD, Gordon RS. The role of the gastrointestinal system in \u201cidiopathic hypoproteinemia.\u201d Gastroenterology. 1961;41:197\u2013207.","journal-title":"Gastroenterology"},{"issue":"7Pt2","key":"3657_CR2","doi-asserted-by":"publisher","first-page":"e88","DOI":"10.1111\/j.1440-1746.2007.05225.x","volume":"23","author":"R Hokari","year":"2008","unstructured":"Hokari R, Kitagawa N, Watanabe C, Komoto S, Kurihara C, Okada Y, et al. Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss. J Gastroenterol Hepatol. 2008;23(7Pt2):e88-95.","journal-title":"J Gastroenterol Hepatol."},{"key":"3657_CR3","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1089\/lrb.2008.1524","volume":"6","author":"DN Finegold","year":"2008","unstructured":"Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, et al. HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol. 2008;6:65\u20138.","journal-title":"Lymphat Res Biol"},{"key":"3657_CR4","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10875-022-01299-1","volume":"42","author":"S Sanges","year":"2022","unstructured":"Sanges S, Germain N, Vignes S, S\u00e9guy D, Stabler S, Etienne N, et al. Protein-losing enteropathy as a complication and\/or differential diagnosis of common variable immunodeficiency. J Clin Immunol. 2022;42:1461\u201372.","journal-title":"J Clin Immunol"},{"key":"3657_CR5","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1750-1172-3-5","volume":"3","author":"S Vignes","year":"2008","unstructured":"Vignes S, Bellanger J. Primary intestinal lymphangiectasia (Waldmann\u2019s disease). Orphanet J Rare Dis. 2008;3:5.","journal-title":"Orphanet J Rare Dis"},{"key":"3657_CR6","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1542\/peds.55.6.842","volume":"55","author":"PA Vardy","year":"1975","unstructured":"Vardy PA, Lebenthal E, Shwachmann H. Intestinal lymphangiectasia: a reappraisal. Pediatrics. 1975;55:842\u201350.","journal-title":"Pediatrics"},{"key":"3657_CR7","first-page":"511","volume":"151","author":"P Le Bougeant","year":"2000","unstructured":"Le Bougeant P, Delbrel X, Grenouillet M, Leou S, Djossou F, Beylot J, et al. Maladie de Waldmann familiale. Ann Med Interne. 2000;151:511\u20132.","journal-title":"Ann Med Interne"},{"key":"3657_CR8","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00431-010-1235-2","volume":"169","author":"MJ Braamskamp","year":"2010","unstructured":"Braamskamp MJ, Dolman KM, Tabbers MM. Clinical practice. Protein-losing enteropathy in children. Eur J Pediatr. 2010;169:1179\u201385.","journal-title":"Eur J Pediatr"},{"key":"3657_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s12876-020-01187-1","volume":"20","author":"N Wang","year":"2020","unstructured":"Wang N, Shi W, Jiao Y. A PTPN11 mutation in a woman with Noonan syndrome and protein-losing enteropathy. BMC Gastroenterol. 2020;20:34.","journal-title":"BMC Gastroenterol"},{"key":"3657_CR10","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1067\/mob.2001.106756","volume":"184","author":"A Schmider","year":"2001","unstructured":"Schmider A, Henrich W, Reles A, Vogel M, Dudenhausen JW. Isolated fetal ascites caused by primary lymphangiectasia: a case report. Am J Obstet Gynecol. 2001;184:227\u20138.","journal-title":"Am J Obstet Gynecol"},{"key":"3657_CR11","doi-asserted-by":"publisher","first-page":"746","DOI":"10.12998\/wjcc.v12.i4.746","volume":"12","author":"JE Na","year":"2024","unstructured":"Na JE, Kim JE, Park S, Kim ER, Hong SN, Kim YH, Chang DK. Experience of primary intestinal lymphangiectasia in adults: twelve case series from a tertiary referral hospital. World J Clin Cases. 2024;12:746\u201357.","journal-title":"World J Clin Cases"},{"key":"3657_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1046\/j.1440-1754.1999.00356.x","volume":"35","author":"WS Lee","year":"1999","unstructured":"Lee WS, Boey CC. Chronic diarrhoea in infants and young children: causes, clinical features and outcome. J Paediatr Child Health. 1999;35:260\u20133.","journal-title":"J Paediatr Child Health"},{"key":"3657_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/j.1075-122X.2005.21578.x","volume":"11","author":"C Goktan","year":"2005","unstructured":"Goktan C, Pekindil G, Orguc S, Coskun T, Serter S. Bilateral breast edema in intestinal lymphangiectasia [letter]. Breast J. 2005;11:360.","journal-title":"Breast J"},{"key":"3657_CR14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000002849","volume":"95","author":"X Wang","year":"2016","unstructured":"Wang X, Jin H, Wu W. Primary intestinal lymphangiectasia manifested as unusual edemas and effusions: a case report. Medicine. 2016;95: e2849.","journal-title":"Medicine"},{"key":"3657_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.revmed.2016.07.005","volume":"38","author":"S Vignes","year":"2017","unstructured":"Vignes S. Les lymph\u0153d\u00e8mes: du diagnostic au traitement. Rev Med Interne. 2017;38:97\u2013105.","journal-title":"Rev Med Interne"},{"key":"3657_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0398-0499(04)96722-4","volume":"29","author":"V Boursier","year":"2004","unstructured":"Boursier V, Vignes S. Lymphangiectasies intestinales primitives (maladie de Waldmann) r\u00e9v\u00e9l\u00e9es par un lymph\u0153d\u00e8me des membres. J Mal Vasc. 2004;29:103\u20136.","journal-title":"J Mal Vasc"},{"key":"3657_CR17","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.gie.2006.10.026","volume":"65","author":"R Rao","year":"2007","unstructured":"Rao R, Shashidhar H. Intestinal lymphangiectasia presenting as abdominal mass. Gastrointest Endosc. 2007;65:522\u20133 (discussion 523).","journal-title":"Gastrointest Endosc"},{"key":"3657_CR18","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ajg.2012.03.001","volume":"13","author":"AB Maamer","year":"2012","unstructured":"Maamer AB, Baazaoui J, Zaafouri H, Soualah W, Cherif A. Primary intestinal lymphangiectasia or Waldmann\u2019s disease: a rare cause of lower gastrointestinal bleeding. Arab J Gastroenterol. 2012;13:97\u20138.","journal-title":"Arab J Gastroenterol"},{"key":"3657_CR19","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/BF00208483","volume":"71","author":"R Lenzhofer","year":"1993","unstructured":"Lenzhofer R, Lindner M, Moser A, Berger J, Schuschnigg C, Thurner J. Acute jejunal ileus in intestinal lymphangiectasia. Clin Investig. 1993;71:568\u201371.","journal-title":"Clin Investig"},{"key":"3657_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1365-2230.1991.tb00322.x","volume":"16","author":"JB O'Driscoll","year":"1991","unstructured":"O\u2019Driscoll JB, Chalmers RJ, Warnes TW. Chylous reflux into abdominal skin simulating lymphangioma circumscriptum in a patient with primary intestinal lymphangiectasia. Clin Exp Dermatol. 1991;16:124\u20136.","journal-title":"Clin Exp Dermatol"},{"key":"3657_CR21","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/S0151-9638(06)70994-2","volume":"133","author":"S Baricault","year":"2006","unstructured":"Baricault S, Soubrane JC, Courville P, Young P, Joly P. Eryth\u00e8me n\u00e9crolytique migrateur au cours d\u2019une maladie de Waldmann. Ann Dermatol Venereol. 2006;133:693\u20136.","journal-title":"Ann Dermatol Venereol"},{"key":"3657_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10354-010-0815-0","volume":"160","author":"CJ Wiedermann","year":"2010","unstructured":"Wiedermann CJ, Kob M, Benvenuti S, Carella R, Lucchin L, Piazzi L, et al. Digital clubbing in primary intestinal lymphangiectasia: a case report. Wien Med Wochenschr. 2010;160:431\u20136.","journal-title":"Wien Med Wochenschr"},{"key":"3657_CR23","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S0929-693X(01)00799-0","volume":"9","author":"A Munck","year":"2002","unstructured":"Munck A, Sosa Valencia G, Faure C, Besnard M, Ferkdadji L, C\u00e9zard JP, et al. Suivi de long cours des lymphangiectasies intestinales primitives de l\u2019enfant. A propos de six cas. Arch Pediatr. 2002;9:388\u201391.","journal-title":"Arch Pediatr"},{"key":"3657_CR24","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1007\/s10620-010-1161-1","volume":"55","author":"J Wen","year":"2010","unstructured":"Wen J, Tang Q, Wu J, Wang Y, Cai W. Primary intestinal lymphangiectasia: four case reports and a review of the literature. Dig Dis Sci. 2010;55:3466\u201372.","journal-title":"Dig Dis Sci"},{"key":"3657_CR25","doi-asserted-by":"publisher","first-page":"413","DOI":"10.5223\/pghn.2021.24.5.413","volume":"24","author":"Y Kwon","year":"2021","unstructured":"Kwon Y, Kim MJ. The update of treatment for primary intestinal lymphangiectasia. Pediatr Gastroenterol Hepatol Nutr. 2021;24:413\u201322.","journal-title":"Pediatr Gastroenterol Hepatol Nutr"},{"key":"3657_CR26","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1097\/MS9.0000000000001850","volume":"86","author":"I Thapaliya","year":"2024","unstructured":"Thapaliya I, Yadav J. Hypocalcaemic tetany linked to vitamin D deficiency and hypomagnesemia in primary intestinal lymphangiectasia: a literature review. Ann Med Surg. 2024;86:2049\u201357.","journal-title":"Ann Med Surg"},{"key":"3657_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1136\/adc.67.1.134","volume":"67","author":"VN Perisic","year":"1992","unstructured":"Perisic VN, Kokai G. Coeliac disease and lymphangiectasia. Arch Dis Child. 1992;67:13\u20136.","journal-title":"Arch Dis Child"},{"key":"3657_CR28","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1365-2133.1964.tb14499.x","volume":"76","author":"P Samman","year":"1964","unstructured":"Samman P, White WF. The \u201cyellow nail\u201d syndrome. Br J Dermatol. 1964;76:153\u20137.","journal-title":"Br J Dermatol"},{"key":"3657_CR29","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13023-017-0594-4","volume":"12","author":"S Vignes","year":"2017","unstructured":"Vignes S, Baran R. Yellow nail syndrome: a review. Orphanet J Rare Dis. 2017;12:42.","journal-title":"Orphanet J Rare Dis"},{"key":"3657_CR30","first-page":"837","volume":"24","author":"J Desram\u00e9","year":"2000","unstructured":"Desram\u00e9 J, B\u00e9chade D, Patte JH, Jean R, Karsenti D, Coutant G, et al. Syndrome des ongles jaunes associ\u00e9 \u00e0 des lymphangiectasies intestinales. Gastroenterol Clin Biol. 2000;24:837\u201340.","journal-title":"Gastroenterol Clin Biol"},{"key":"3657_CR31","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000535577","volume":"240","author":"E Benassaia","year":"2024","unstructured":"Benassaia E, Abba S, Fourgeaud C, Mihoubi A, Vignes S. Yellow nail syndrome: analysis of 23 consecutive patients and effect of combined fluconazole-vitamin-E treatment. Dermatology. 2024;240:343\u201351.","journal-title":"Dermatology"},{"key":"3657_CR32","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1002\/ajmg.1320340429","volume":"34","author":"RC Hennekam","year":"1989","unstructured":"Hennekam RC, Geerdink RA, Hamel BC, Hennekam FA, Kraus P, Rammeloo JA, et al. Autosomal recessive intestinal lymphangiectasia and lymphedema, with facial anomalies and mental retardation. Am J Med Genet. 1989;34:593\u2013600.","journal-title":"Am J Med Genet"},{"key":"3657_CR33","doi-asserted-by":"publisher","first-page":"8085","DOI":"10.1038\/ncomms9085","volume":"6","author":"E Fotiou","year":"2015","unstructured":"Fotiou E, Martin-Almedina S, Simpson MA, Lin S, Gordon K, Brice G, et al. Novel mutations in PIEZO1 cause an autosomal recessive generalized lymphatic dysplasia with non-immune hydrops fetalis. Nat Commun. 2015;6:8085.","journal-title":"Nat Commun"},{"key":"3657_CR34","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/ajmg.a.37148","volume":"167A","author":"SF Pollack","year":"2015","unstructured":"Pollack SF, Geffrey AL, Thiele EA, Shah U. Primary intestinal lymphangiectasia treated with rapamycin in a child with tuberous sclerosis complex (TSC). Am J Med Genet A. 2015;167A:2209\u201312.","journal-title":"Am J Med Genet A"},{"key":"3657_CR35","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.gie.2006.01.032","volume":"64","author":"C Calabrese","year":"2006","unstructured":"Calabrese C, Pironi L, Di Febo G. Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. Gastrointest Endosc. 2006;64:130\u20131.","journal-title":"Gastrointest Endosc"},{"key":"3657_CR36","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1056\/NEJMoa1615887","volume":"377","author":"A Ozen","year":"2017","unstructured":"Ozen A, Comrie WA, Ardy RC, Dom\u00ednguez Conde C, Dalgic B, Beser \u00d6F, et al. CD55 deficiency, early-onset protein-losing enteropathy, and thrombosis. N Engl J Med. 2017;377:52\u201361.","journal-title":"N Engl J Med"},{"issue":"1","key":"3657_CR37","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1136\/jmedgenet-2021-107820","volume":"60","author":"S Mansour","year":"2023","unstructured":"Mansour S, Josephs KS, Ostergaard P, Gordon K, van Zanten M, Pearce J, et al. Redefining WILD syndrome: a primary lymphatic dysplasia with congenital multisegmental lymphoedema, cutaneous lymphovascular malformation, CD4 lymphopaenia and warts. J Med Genet. 2023;60(1):84\u201390.","journal-title":"J Med Genet"},{"key":"3657_CR38","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00431-007-0445-8","volume":"167","author":"J Lee","year":"2008","unstructured":"Lee J, Kong MS. Primary intestinal lymphangiectasia diagnosed by endoscopy following the intake of a high-fat meal. Eur J Pediatr. 2008;167:237\u20139.","journal-title":"Eur J Pediatr"},{"key":"3657_CR39","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.dld.2006.01.027","volume":"38","author":"P Chamouard","year":"2006","unstructured":"Chamouard P, Nehme-Schuster H, Simler JM, Finck G, Baumann R, Pasquali JL. Videocapsule endoscopy is useful for the diagnosis of intestinal lymphangiectasia. Dig Liver Dis. 2006;38:699\u2013703.","journal-title":"Dig Liver Dis"},{"key":"3657_CR40","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.revmed.2006.11.019","volume":"28","author":"S Vignes","year":"2007","unstructured":"Vignes S, Bellanger J. Int\u00e9r\u00eat de l\u2019ent\u00e9roscopie par vid\u00e9ocapsule dans le diagnostic des lymphangiectasies intestinales primitives. Rev Med Interne. 2007;28:173\u20135.","journal-title":"Rev Med Interne"},{"key":"3657_CR41","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000177027","volume":"26","author":"AV Safatle-Ribeiro","year":"2008","unstructured":"Safatle-Ribeiro AV, Iriya K, Couto DS, Kawaguti FS, Retes F, Ribeiro U Jr, et al. Secondary lymphangiectasia of the small bowel: utility of double balloon enteroscopy for diagnosis and management. Dig Dis. 2008;26:383\u20136.","journal-title":"Dig Dis"},{"key":"3657_CR42","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.gie.2006.03.008","volume":"64","author":"C Rivet","year":"2006","unstructured":"Rivet C, Lapalus MG, Dumortier J, Le Gall C, Budin C, Bouvier R, et al. Use of capsule endoscopy in children with primary intestinal lymphangiectasia. Gastrointest Endosc. 2006;64:649\u201350.","journal-title":"Gastrointest Endosc"},{"key":"3657_CR43","doi-asserted-by":"crossref","DOI":"10.1097\/MPG.0000000000001586","volume":"64","author":"SM van der Reijden","year":"2017","unstructured":"van der Reijden SM, van Wijk MP, Jacobs MA, de Meij TG. Video capsule endoscopy to diagnose primary intestinal lymphangiectasia in a 14-month-old child. J Pediatr Gastroenterol Nutr. 2017;64: e161.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR44","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1752-1947-7-19","volume":"7","author":"Y Lai","year":"2013","unstructured":"Lai Y, Yu T, Qiao XY, Zhao LN, Chen QK. Primary intestinal lymphangiectasia diagnosed by double-balloon enteroscopy and treated by medium-chain triglycerides: a case report. J Med Case Rep. 2013;7:19.","journal-title":"J Med Case Rep"},{"key":"3657_CR45","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1097\/MPG.0b013e3181d2979c","volume":"51","author":"TK Lin","year":"2010","unstructured":"Lin TK, Erdman SH. Double-balloon enteroscopy: pediatric experience. J Pediatr Gastroenterol Nutr. 2010;51:429\u201332.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR46","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.revmed.2014.12.001","volume":"36","author":"A Amiot","year":"2015","unstructured":"Amiot A. Gastro-ent\u00e9ropathies exsudatives. Rev Med Interne. 2015;36:467\u201373.","journal-title":"Rev Med Interne"},{"key":"3657_CR47","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3390\/nu13041185","volume":"13","author":"M Martinat","year":"2021","unstructured":"Martinat M, Rossitto M, Di Miceli M, Lay\u00e9 S. Perinatal dietary polyunsaturated fatty acids in brain development, role in neurodevelopmental disorders. Nutrients. 2021;13:1185.","journal-title":"Nutrients"},{"key":"3657_CR48","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1148\/radiology.219.1.r01ap2986","volume":"219","author":"NT Chiu","year":"2001","unstructured":"Chiu NT, Lee BF, Hwang SJ, Chang JM, Liu GC, Yu HS. Protein-losing enteropathy: diagnosis with 99mTc-labeled human serum albumin scintigraphy. Radiology. 2001;219:86\u201390.","journal-title":"Radiology"},{"key":"3657_CR49","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0929-8266(98)00037-8","volume":"7","author":"G Maconi","year":"1998","unstructured":"Maconi G, Molteni P, Manzionna G, Parente F, Bianchi PG. Ultrasonographic features of long-standing primary intestinal lymphangiectasia. Eur J Ultrasound. 1998;7:195\u20138.","journal-title":"Eur J Ultrasound"},{"key":"3657_CR50","first-page":"767","volume":"9","author":"A Fakhri","year":"1985","unstructured":"Fakhri A, Fishman EK, Jones B, Kuhadja F, Siegelman SS. Primary intestinal lymphangiectasia: clinical and CT findings. J Comput Assist Tomogr. 1985;9:767\u201370.","journal-title":"J Comput Assist Tomogr"},{"key":"3657_CR51","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s00247-014-3191-x","volume":"45","author":"LJ Malone","year":"2015","unstructured":"Malone LJ, Fenton LZ, Weinman JP, Anagnost MR, Browne LP. Pediatric lymphangiectasia: an imaging spectrum. Pediatr Radiol. 2015;45:562\u20139.","journal-title":"Pediatr Radiol"},{"key":"3657_CR52","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/00006231-200111000-00013","volume":"22","author":"Y So","year":"2001","unstructured":"So Y, Chung JK, Seo JK, Ko JS, Kim JY, Lee DS, et al. Different patterns of lymphoscintigraphic findings in patients with intestinal lymphangiectasia. Nucl Med Commun. 2001;22:1249\u201354.","journal-title":"Nucl Med Commun"},{"key":"3657_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/1754-9485.12606","volume":"61","author":"X Sun","year":"2017","unstructured":"Sun X, Shen W, Chen X, Wen T, Duan Y, Wang R. Primary intestinal lymphangiectasia: multiple detector computed tomography findings after direct lymphangiography. J Med Imaging Radiat Oncol. 2017;61:607\u201313.","journal-title":"J Med Imaging Radiat Oncol"},{"key":"3657_CR54","first-page":"111","volume":"41","author":"NF Liu","year":"2008","unstructured":"Liu NF, Lu Q, Wang CG, Zhou JG. Magnetic resonance imaging as a new method to diagnose protein losing enteropathy. Lymphology. 2008;41:111\u20135.","journal-title":"Lymphology"},{"key":"3657_CR55","doi-asserted-by":"publisher","first-page":"5879","DOI":"10.1007\/s00330-019-06151-6","volume":"29","author":"L Arriv\u00e9","year":"2019","unstructured":"Arriv\u00e9 L, Monnier-Cholley L, Cazzagon N, Wendum D, Chambenois E, El Mouhadi S. Non-contrast MR lymphography of the lymphatic system of the liver. Eur Radiol. 2019;29:5879\u201388.","journal-title":"Eur Radiol"},{"key":"3657_CR56","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1097\/MPG.0000000000003287","volume":"74","author":"JN Brownell","year":"2022","unstructured":"Brownell JN, Biko DM, Mamula P, Krishnamurthy G, Escobar F, Srinivasan A, et al. Dynamic contrast magnetic resonance lymphangiography localizes lymphatic leak to the duodenum in protein-losing enteropathy. J Pediatr Gastroenterol Nutr. 2022;74:38\u201345.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR57","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000201124","volume":"55","author":"D Heresbach","year":"1994","unstructured":"Heresbach D, Raoul JL, Genetet N, Noret P, Siproudhis L, Ramee MP, et al. Immunological study in primary intestinal lymphangiectasia. Digestion. 1994;55:59\u201364.","journal-title":"Digestion"},{"key":"3657_CR58","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1086\/606059","volume":"49","author":"M Malphettes","year":"2009","unstructured":"Malphettes M, G\u00e9rard L, Carmagnat M, Mouillot G, Vince N, Boutboul D, et al. DEFI Study Group. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49:1329\u201338.","journal-title":"Clin Infect Dis"},{"key":"3657_CR59","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1080\/00365520802321220","volume":"44","author":"S Vignes","year":"2009","unstructured":"Vignes S, Carcelain G. Increased surface receptor Fas (CD95) levels on CD4+ lymphocytes in patients with primary intestinal lymphangiectasia. Scand J Gastroenterol. 2009;44:252\u20136.","journal-title":"Scand J Gastroenterol"},{"key":"3657_CR60","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1186\/s12876-021-01997-x","volume":"21","author":"D Hu","year":"2021","unstructured":"Hu D, Cui X, Ren W, Zhang J, Guan X, Jiang X. A case of primary intestinal lymphangiectasia with non-Hodgkin lymphoma. BMC Gastroenterol. 2021;21:461.","journal-title":"BMC Gastroenterol"},{"key":"3657_CR61","first-page":"319","volume":"135","author":"S Chegini","year":"2010","unstructured":"Chegini S, Hershey PA. Successful management of primary intestinal lymphangiectasia with subcutaneous immunoglobulin (SCIG) and octreotide. Clin Immunol. 2010;135:319\u201320.","journal-title":"Clin Immunol"},{"key":"3657_CR62","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S1081-1206(10)60765-X","volume":"98","author":"SL Cole","year":"2007","unstructured":"Cole SL, Ledford DK, Lockey RF, Daas A, Kooper J. Primary gastrointestinal lymphangiectasia presenting as cryptococcal meningitis. Ann Allergy Asthma Immunol. 2007;98:490\u20132.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"3657_CR63","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s10096-023-04657-y","volume":"42","author":"M Mathurin","year":"2023","unstructured":"Mathurin M, Devatine S, Kopp-Derouet A, Guillonnet A, Alanio A, Lourenco N, et al. Cryptococcal meningitis and cerebral vasculitis in a patient with primary intestinal lymphangiectasia: a case report. Eur J Clin Microbiol Infect Dis. 2023;42:1263\u20137.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3657_CR64","doi-asserted-by":"publisher","first-page":"7870154","DOI":"10.1155\/2020\/7870154","volume":"2020","author":"F Naranjo-Saltos","year":"2020","unstructured":"Naranjo-Saltos F, Hallo A, Hallo C, Mayancela A, Rojas A. Gastrointestinal cryptococcosis associated with intestinal lymphangiectasia. Case Rep Med. 2020;2020:7870154.","journal-title":"Case Rep Med"},{"key":"3657_CR65","doi-asserted-by":"publisher","first-page":"8467","DOI":"10.3748\/wjg.v21.i27.8467","volume":"21","author":"SJ Lee","year":"2015","unstructured":"Lee SJ, Song HJ, Boo SJ, Na SY, Kim HU, Hyun CL. Primary intestinal lymphangiectasia with generalized warts. World J Gastroenterol. 2015;21:8467\u201372.","journal-title":"World J Gastroenterol"},{"key":"3657_CR66","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1136\/pgmj.53.626.753","volume":"53","author":"M Ward","year":"1977","unstructured":"Ward M, Le Roux A, Small WP, Sircus W. Malignant lymphoma and extensive viral wart formation in a patient with intestinal lymphangiectasia and lymphocyte depletion. Postgrad Med J. 1977;53:753\u20137.","journal-title":"Postgrad Med J"},{"key":"3657_CR67","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/01.mpg.0000233192.77521.2f","volume":"44","author":"MP Dierselhuis","year":"2007","unstructured":"Dierselhuis MP, Boelens JJ, Versteegh FG, Weemaes C, Wulffraat NM. Recurrent and opportunistic infections in children with primary intestinal lymphangiectasia. J Pediatr Gastroenterol Nutr. 2007;44:382\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR68","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0002-9343(99)00035-2","volume":"107","author":"I Marie","year":"1999","unstructured":"Marie I, L\u00e9vesque H, H\u00e9ron F, Courtois H, Callat MP. Gelatinous transformation of the bone marrow: an uncommon manifestation of intestinal lymphangiectasia (Waldmann\u2019s disease). Am J Med. 1999;107:99\u2013100.","journal-title":"Am J Med"},{"key":"3657_CR69","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1159\/000190232","volume":"76","author":"R Bogdanovi\u0107","year":"1997","unstructured":"Bogdanovi\u0107 R, Stankovi\u0107 I, Joji\u0107 N, Ognjanovi\u0107 M, Zlatkovi\u0107 M, Popovi\u0107 O, et al. Recurrent hemolytic uremic syndrome with hypocomplementemia and intestinal lymphangiectasia. Nephron. 1997;76:481\u20134.","journal-title":"Nephron"},{"key":"3657_CR70","first-page":"246","volume":"20","author":"S Kalman","year":"2007","unstructured":"Kalman S, Bakkalo\u011flu S, Dalgi\u00e7 B, Ozkaya O, S\u00f6ylemezo\u011flu O, Buyan N. Recurrent hemolytic uremic syndrome associated with intestinal lymphangiectasia. J Nephrol. 2007;20:246\u20139.","journal-title":"J Nephrol"},{"key":"3657_CR71","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.27025","volume":"60","author":"L Milazzo","year":"2014","unstructured":"Milazzo L, Peri AM, Lodi L, Gubertini G, Ridolfo AL, Antinori S. Intestinal lymphangiectasia and reversible high liver stiffness. Hepatology. 2014;60:759\u201361.","journal-title":"Hepatology"},{"key":"3657_CR72","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4254\/wjh.v6.i9.685","volume":"6","author":"R Licinio","year":"2014","unstructured":"Licinio R, Principi M, Ierardi E, Di Leo A. Liver fibrosis in primary intestinal lymphangiectasia: an undervalued topic. World J Hepatol. 2014;6:685\u20137.","journal-title":"World J Hepatol"},{"key":"3657_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jbspin.2007.01.045","volume":"75","author":"H Sahli","year":"2008","unstructured":"Sahli H, Ben Mbarek R, Elleuch M, Azzouz D, Meddeb N, Ch\u00e9our E, et al. Osteomalacia in a patient with primary intestinal lymphangiectasis (Waldmann\u2019s disease). Joint Bone Spine. 2008;75:73\u20135.","journal-title":"Joint Bone Spine"},{"key":"3657_CR74","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1542\/peds.34.5.629","volume":"34","author":"PR Holt","year":"1964","unstructured":"Holt PR. Dietary treatment of protein loss in intestinal lymphangiectasia. The effect of eliminating dietary long chain triglycerides on albumin metabolism in this condition. Pediatrics. 1964;34:629\u201335.","journal-title":"Pediatrics"},{"key":"3657_CR75","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1007\/s13197-022-05499-w","volume":"60","author":"HB Jadhav","year":"2023","unstructured":"Jadhav HB, Annapure US. Triglycerides of medium-chain fatty acids: a concise review. J Food Sci Technol. 2023;60:2143\u201352.","journal-title":"J Food Sci Technol"},{"key":"3657_CR76","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0899-9007(00)00223-9","volume":"16","author":"V Alfano","year":"2000","unstructured":"Alfano V, Tritto G, Alfonsi L, Cella A, Pasanisi F, Contaldo F. Stable reversal of pathologic signs of primitive intestinal lymphangiectasia with a hypolipidic, MCT-enriched diet. Nutrition. 2000;16:303\u20134.","journal-title":"Nutrition"},{"key":"3657_CR77","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10620-005-2863-7","volume":"50","author":"K Aoyagi","year":"2005","unstructured":"Aoyagi K, Iida M, Matsumoto T, Sakisaka S. Enteral nutrition as a primary therapy for intestinal lymphangiectasia: value of elemental diet and polymeric diet compared with total parenteral nutrition. Dig Dis Sci. 2005;50:1467\u201370.","journal-title":"Dig Dis Sci"},{"key":"3657_CR78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.jacl.2022.08.009","volume":"16","author":"C Bredefeld","year":"2022","unstructured":"Bredefeld C, Hussain MM, Averna M, Black DD, Brin MF, Burnett JR, Charri\u00e8re S, et al. Guidance for the diagnosis and treatment of hypolipidemia disorders. J Clin Lipidol. 2022;16:797\u2013812.","journal-title":"J Clin Lipidol"},{"key":"3657_CR79","first-page":"699","volume":"10","author":"AB Ballinger","year":"1998","unstructured":"Ballinger AB, Farthing MJ. Octreotide in the treatment of intestinal lymphangiectasia. Eur J Gastroenterol Hepatol. 1998;10:699\u2013702.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"3657_CR80","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1097\/MPG.0b013e3181d1b162","volume":"51","author":"S Sari","year":"2010","unstructured":"Sari S, Baris Z, Dalgic B. Primary intestinal lymphangiectasia in children: is octreotide an effective and safe option in the treatment? J Pediatr Gastroenterol Nutr. 2010;51:454\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR81","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.3748\/wjg.v18.i43.6333","volume":"18","author":"S Al Sinani","year":"2012","unstructured":"Al Sinani S, Rawahi YA, Abdoon H. Octreotide in Hennekam syndrome-associated intestinal lymphangiectasia. World J Gastroenterol. 2012;18:6333\u20137.","journal-title":"World J Gastroenterol"},{"key":"3657_CR82","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/MPG.0b013e31822d2dd4","volume":"54","author":"G Altit","year":"2012","unstructured":"Altit G, Patel H, Morinville VD. Octreotide management of intestinal lymphangiectasia in a teenage heart transplant patient. J Pediatr Gastroenterol Nutr. 2012;54:824\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"3657_CR83","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1002\/pbc.23124","volume":"57","author":"AM Hammill","year":"2011","unstructured":"Hammill AM, Wentzel M, Gupta A, Nelson S, Lucky A, Elluru R, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57:1018\u201324.","journal-title":"Pediatr Blood Cancer"},{"key":"3657_CR84","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-3257","volume":"137","author":"DM Adams","year":"2016","unstructured":"Adams DM, Trenor CC 3rd, Hammill AM, Vinks AA, Patel MN, Chaudry G, et al. Efficacy and safety of sirolimus in the treatment of complicated vascular anomalies. Pediatrics. 2016;137: e20153257.","journal-title":"Pediatrics"},{"key":"3657_CR85","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1345\/aph.19380","volume":"34","author":"GR Ingle","year":"2000","unstructured":"Ingle GR, Sievers TM, Holt CD. Sirolimus: continuing the evolution of transplant immunosuppression. Ann Pharmacother. 2000;34:1044\u201355.","journal-title":"Ann Pharmacother"},{"key":"3657_CR86","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s12887-020-02447-5","volume":"21","author":"Y Kwon","year":"2021","unstructured":"Kwon Y, Kim ES, Choe YH, Kim MJ. Individual approach for treatment of primary intestinal lymphangiectasia in children: single-center experience and review of the literature. BMC Pediatr. 2021;21:21.","journal-title":"BMC Pediatr"},{"key":"3657_CR87","doi-asserted-by":"publisher","first-page":"448","DOI":"10.2340\/00015555-2300","volume":"96","author":"M Nadal","year":"2016","unstructured":"Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A. Efficacy and safety of mammalian target of rapamycin inhibitors in vascular anomalies: a systematic review. Acta Derm Venereol. 2016;96:448\u201352.","journal-title":"Acta Derm Venereol"},{"key":"3657_CR88","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2015-2562","volume":"137","author":"M Ozeki","year":"2016","unstructured":"Ozeki M, Hori T, Kanda K, Kawamoto N, Ibuka T, Miyazaki T, et al. Everolimus for primary intestinal lymphangiectasia with protein-losing enteropathy. Pediatrics. 2016;137: e20152562.","journal-title":"Pediatrics"},{"key":"3657_CR89","first-page":"155","volume":"25","author":"CJ Liviskie","year":"2020","unstructured":"Liviskie CJ, Brennan CC, McPherson CC, Vesoulis ZA. Propranolol for the treatment of lymphatic malformations in a neonate\u2014a case report and review of literature. J Pediatr Pharmacol Ther. 2020;25:155\u201362.","journal-title":"J Pediatr Pharmacol Ther"},{"key":"3657_CR90","doi-asserted-by":"publisher","first-page":"e439","DOI":"10.1542\/peds.2012-2087","volume":"133","author":"C Poralla","year":"2014","unstructured":"Poralla C, Specht S, Born M, M\u00fcller A, Bartmann P, M\u00fcller A. Treatment of congenital generalized lymphangiectasia with propranolol in a preterm infant. Pediatrics. 2014;133:e439\u201342.","journal-title":"Pediatrics"},{"key":"3657_CR91","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1136\/adc.78.2.194","volume":"78","author":"M Persic","year":"1998","unstructured":"Persic M, Browse NL, Prpic I. Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel resection. Arch Dis Child. 1998;78:194.","journal-title":"Arch Dis Child"},{"key":"3657_CR92","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jpedsurg.2009.06.034","volume":"44","author":"NR Kim","year":"2009","unstructured":"Kim NR, Lee SK, Suh YL. Primary intestinal lymphangiectasia successfully treated by segmental resections of small bowel. J Pediatr Surg. 2009;44:e13\u20137.","journal-title":"J Pediatr Surg"},{"key":"3657_CR93","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3349\/ymj.2021.62.5.470","volume":"62","author":"Y Kwon","year":"2021","unstructured":"Kwon Y, Kim ES, Choe YH, Hyun D, Kim MJ. Therapeutic lymphatic embolization in pediatric primary intestinal lymphangiectasia. Yonsei Med J. 2021;62:470\u20133.","journal-title":"Yonsei Med J"},{"key":"3657_CR94","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1111\/resp.12357","volume":"19","author":"L Valdes","year":"2014","unstructured":"Valdes L, Huggins JT, Gude F, Ferreiro L, Alvarez-Dobano JM, Golpe A, et al. Characteristics of patients with yellow nail syndrome and pleural effusion. Respirology. 2014;19:985\u201392.","journal-title":"Respirology"},{"key":"3657_CR95","doi-asserted-by":"publisher","first-page":"254","DOI":"10.12688\/f1000research.5538.1","volume":"3","author":"S Mummadi","year":"2014","unstructured":"Mummadi S, Kumbam A, Hahn P. Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis. F1000Res. 2014;3:254.","journal-title":"F1000Res"},{"issue":"4","key":"3657_CR96","first-page":"CD010529","volume":"4","author":"A Dipper","year":"2020","unstructured":"Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev. 2020;4(4):CD010529.","journal-title":"Cochrane Database Syst Rev"},{"key":"3657_CR97","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13023-020-01652-w","volume":"16","author":"S Vignes","year":"2021","unstructured":"Vignes S, Albuisson J, Champion L, Constans J, Tauveron V, Malloizel J, et al. French National Referral Center for Primary Lymphedema. Primary lymphedema French National Diagnosis and Care Protocol (PNDS; Protocole National de Diagnostic et de Soins). Orphanet J Rare Dis. 2021;16:18.","journal-title":"Orphanet J Rare Dis"},{"key":"3657_CR98","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jvsv.2021.04.009","volume":"10","author":"S Vignes","year":"2022","unstructured":"Vignes S, Poizeau F, Dupuy A. Cellulitis risk factors for patients with primary or secondary lymphedema. J Vasc Surg Venous Lymphat Disord. 2022;10:179-85.e1.","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"key":"3657_CR99","first-page":"517","volume":"29","author":"MP Quemere","year":"2000","unstructured":"Quemere MP, Descargues G, Verspyck E, Marpeau L. Maladie de Waldmann et grossesse. J Gynecol Obstet Biol Reprod. 2000;29:517\u20139.","journal-title":"J Gynecol Obstet Biol Reprod"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03657-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03657-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03657-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T05:48:55Z","timestamp":1757224135000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03657-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,10]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3657"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03657-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,10]]},"assertion":[{"value":"3 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}